Address
Johnson & Johnson Development Corp Inc
410 George Street
New Brunswick, NJ 08933
United States
Phone
Website
Recent investment activity
KANDO id: 1964
Corporate information
Official name
Johnson & Johnson Innovation LLC
Also known as
JJDC Inc
Johnson & Johnson Development Corp Inc
Registration country
Company type
Accelerator of early-stage innovation worldwide that forms collaborations between entrepreneurs and Johnson & Johnson’s global healthcare businesses.Relation
Funding rounds
Investment preferences
Investment activity status
Active investor
Selected investments
Displaying 1 - 25 of 83| Company | Profile | Country | Date | Funding | ||
|---|---|---|---|---|---|---|
![[current-page:title] logo](/sites/default/files/styles/icon/public/default_images/_no-logo.png?itok=AH4pbDYM){kind=icon}
|
Allos Therapeutics Inc | N/A | ||||
|
|
Archus Orthopedics Inc | Spinal and orthopedic implant and instrument company. | Series C | |||
|
|
Astute Medical Inc | Dedicated to improving the diagnosis of high-risk medical conditions and diseases through the identification and validation of protein biomarkers | Series C | |||
|
|
Astute Medical Inc | Dedicated to improving the diagnosis of high-risk medical conditions and diseases through the identification and validation of protein biomarkers | Series B | |||
|
|
ATI Medical Inc | N/A | ||||
|
|
Atrionix Inc | N/A | ||||
|
|
Axial Biotech Inc | Series B | ||||
|
|
Axya Medical Inc | N/A | ||||
|
|
BioCryst Pharmaceuticals Inc | N/A | ||||
|
|
BioRexis Pharmaceutical Corp | Series B | ||||
|
|
Cardiac Dimensions Inc | Medical device company developing novel interventional tools for the treatment of heart failure & the related condition of mitral valve regurgitation. | N/A | |||
|
|
Cardio Polymers Inc | Biopharmaceutical company focused on non-destructive treatments for cardiac conduction abnormalities. | N/A | |||
|
|
Catalyst Biosciences Inc | Developer of catalytic biopharmaceutical products based on engineered human proteases. | Series C | |||
|
|
Celladon Corp | N/A | ||||
|
|
Centocor Inc | Acquisition | ||||
|
|
CoAxia Inc | A medical device company that researches therapy and treatment solutions for cerebral ischemia | Series D | |||
|
|
Collabrys Inc | Technology-based marketing solutions company. | Series B | |||
|
|
Critical Therapeutics Inc | Discoverer, developer and commercialize novel therapies. | N/A | |||
|
|
Cyrano Sciences Inc | Electronic nose for homeland defense applications | N/A | |||
|
|
Delsys Pharmaceutical Corp | Develops technology for drug development and manufacture. | N/A | |||
|
|
Digirad Corp | Solid-state gamma cameras company for nuclear cardiology and general nuclear medicine applications. | N/A | |||
|
|
Five Prime Therapeutics Inc | N/A | ||||
|
|
Genocea Biosciences Inc | Series B | ||||
|
|
GetWellNetwork Inc | N/A | ||||
|
|
Immunicon Corp | Biotechnology company specializing in cell-based research and diagnostic products with an initial focus on cancer. | N/A |
Team
| Employee | Position | |||
|---|---|---|---|---|
| Roger J Guidi | Vice President
Venture Investments |
|||
| Carol A Marino | Vice President
Venture Investments |
|||
| Richard V McCloskey | [email protected] | |||
| Brad H Vale | Vice President
Venture Investments |
|||
| Zeev Zehavi | Vice President
Venture Investments |
[email protected] | ||
| Dana Gelbaum | ||||
| David P Holveck | ||||
| Asish K Xavier |